Company intelligence / Profile preview

Babybe

Stuttgart, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

Babybe has developed and commercialized a CE‑marked bionic mattress system used in neonatal intensive care to transmit a mother’s biosignals to her premature baby in an incubator, aiming to reduce stress and support development; it is a device solution and not a drug, so there are no conventional clinical trial phases reported, though the product is in commercial clinical use[1][2][5].

Therapeutic areas: PsychiatryWomen's Health
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Babybe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Babybe.

Explore the full profile